Dr. Hang Quach on Belantamab Mafodotin in MM

By Blood Cancer Talks - Last Updated: November 21, 2024

In this episode of “Blood Cancer Talks,” Hang Quach, MBBS, of The University of Melbourne, joins hosts Rajshekhar Chakraborty, MD; Edward Cliff, MD; and Ashwin Kishtagari, MD; for a conversation on belantamab mafodotin in multiple myeloma (MM).

Advertisement

The group discusses four abstracts presented at the European Hematology Association 2024 Congress and the American Society of Clinical Oncology Annual Meeting, including:

  • DREAMM-7: Belantamab-Vd versus D-Vd
  • DREAMM-8: Belantamab-Pd versus PVd
  • CASSIOPEIA Trial: D-VTd versus VTd
  • PERSEUS Trial: Daratumumab versus D-VRd

This podcast originally appeared on Blood Cancer Talks.

Advertisement
Advertisement
Advertisement
Editorial Board